Evolus June 2023 Investor Presentation

Evolus presents its June 2023 investor update covering the commercial trajectory of Jeuveau® and the development pipeline for Evolysse™ dermal fillers. The presentation discusses market strategy, regulatory progress, and financial performance in the aesthetic medicine sector.